$6.05
-0.06 (-0.98%)
Market Cap
$187.0M
Shares Outstanding
18,702,696
Institutional Holders
32
Total Inst. Value
$124.1M
% of Float Held
—
QoQ Holder Change
—
Institutional data as of Q1 2025
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | Samsara BioCapital, LLC | $91.9M | 11,448,081 |
| 2 | Octagon Capital Advisors LP | $16.6M | 2,763,000 |
| 3 | GILEAD SCIENCES, INC. | $5.8M | 723,273 |
| 4 | TANG CAPITAL MANAGEMENT LLC | $2.5M | 309,221 |
| 5 | Siren, L.L.C. | $2.3M | 282,586 |
| 6 | EcoR1 Capital, LLC | $1.6M | 201,718 |
| 7 | VANGUARD GROUP INC | $923K | 115,086 |
| 8 | Redmile Group, LLC | $666K | 82,955 |
| 9 | BlackRock, Inc. | $221K | 27,514 |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | $214K | 26,787 |
Famous Fund Managers
Related Stocks
Frequently Asked Questions
How many institutional investors hold KLRS?
As of Q1 2025, 32 institutional investors report holding KLRS (Kalaris Therapeutics Inc) in their 13F filings.
Which hedge fund owns the most KLRS?
The largest institutional holder of KLRS is Samsara BioCapital, LLC with $91.9M in shares.
Are institutions buying or selling KLRS?
This quarter, 32 institutions opened new positions in KLRS and 0 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.